Collectively, findings obtained in the current in silico study provide evidence for the prognostic evaluation in esophageal cancer following radiotherapy by targeting the miR-132-3p/CAND1/ZDHHC23 and miR-576-5p/AHR pathways (Fig. 8). This evidence concerns the gene AHR and esophageal cancer.